Product Program year 2025 Source: CMS Open Payments

Ceprotin

Biological Immunology

NDC 0944-4175-05

Open in the dashboard

General payments

$71,435

29 payments

Research payments

$5,195

3 payments

Through program year 2025, $71,435 in general payments and $5,195 in research payments were reported against Ceprotin (Immunology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $7,763 7
2025 Research $200 1
2024 General $13,250 1
2023 General $27,828 11
2022 General $22,595 10
2022 Research $4,995 2

Breakdown

Who paid General payments · program years 2022–2025
  1. Takeda Pharmaceuticals U.S.A., Inc. $71,435 29 payments
Top recipients General payments · program year 2025
  1. Robert Sidonio Pediatric Hematology-Oncology · Atlanta, GA $3,263 42% · 1 payment
  2. Guy Young Pediatric Hematology-Oncology · Bozeman, MT $2,250 29% · 3 payments
  3. Ellis Neufeld Pediatric Hematology-Oncology · Memphis, TN $750 10% · 1 payment
  4. Julie Jaffray Pediatric Hematology-Oncology · San Diego, CA $750 10% · 1 payment
  5. Jenny Zhou Hematology & Oncology · San Diego, CA $750 10% · 1 payment

Each share is of general payments naming this product in 2025.

Specialties paid General payments · program year 2025
  1. Pediatric Hematology-Oncology Pediatrics $7,013 90% · 4 practitioners
  2. Hematology & Oncology Internal Medicine $750 10% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Georgia $3,263 42% · 1 recipient
  2. Montana $2,250 29% · 1 recipient
  3. California $1,500 19% · 2 recipients
  4. Tennessee $750 10% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

29 general · 3 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record